跳至主要内容
临床试验/NCT02994043
NCT02994043已完成不适用

Dismantling MBRP: Identifying Critical Neuroimmune Mechanisms of Action.

University of Colorado, Denver2 个研究点 分布在 1 个国家目标入组 182 人开始时间: 2016年11月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
182
试验地点
2
主要终点
Heavy Drinking Days at Baseline

研究概览

简要总结

The goal of the AIM Study is to examine the effectiveness of Mindfulness Based Relapse Prevention (MBRP) versus Relapse Prevention (RP) for the treatment of Alcohol Use Disorders (AUD) by implementing an 8-week long intervention and examining neurobiological, immunological, and epigenetic characteristics of AUD.

详细描述

This study was designed to evaluate the effect of two outpatient, individually-administered, psychosocial interventions (Relapse Prevention vs. Mindfulness-Based Relapse Prevention). Participants are recruited via mass media advertisements, flyers, and local outreach to clinical providers that do not address substance use. We will recruit 226 individuals. Our previous experience with clinical trials, as well as the experience of our research team members with these interventions support the feasibility of recruiting approximately 50 patients per year. This sample size provides adequate statistical power for the research questions undertaken.

Participants are screened over the telephone and invited into the laboratory for a baseline assessment. Immediately after the baseline assessment, they are randomized to a therapist and then to a treatment condition. At the end of each year, the distribution of participants across conditions and therapists are evaluated for imbalances. If attrition has resulted in an imbalance across conditions, the randomization procedure will be adjusted to ensure equal numbers of participants in RP and MBRP.

Within a week of completing the baseline assessments, participants are seen by their individual therapist for a motivational interviewing, goal-setting session. After the goal-setting session, the eight-session MBRP or RP treatments are administered. To ensure that therapists adhere to treatment manuals, a checklist is provided consisting of the primary content addressed each session (four to seven primary content pieces each session). Further, questionnaires assessing mindfulness practice and facets of mindfulness (e.g., being nonjudgmental, nonreactive) are administered at each assessment. At the most recent RPPR, these questionnaires validated that participants in the MBRP condition were increasing in some facets of mindfulness during treatment (and up to three months after treatment).

We estimate that the completion of assessments and procedures across the duration of the trial, excluding therapy sessions, will total about 15 hours of time. To compensate subjects for their time and travel costs, each subject will be paid $300 if they complete all sessions.

We will conduct extensive analyses of any attrition encountered in the project to determine bias. However, note that in each of the analyses described herein, we will have the capability of using modern approaches to the handling of missing data including full information maximum likelihood estimation of missing data within Proc Mixed in SAS and within EQS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Have a primary Diagnostic Statistical Manual-V (DSM-V) diagnosis of alcohol use disorder;
  • Must be within 10 days of last drink;
  • Must have been drinking heavily (criteria dependent upon individual?s age, gender, and BMI) for a consistent period of time;
  • Must have a breath alcohol level of 0 at screening;
  • Must have a Clinical Institute Withdrawal Assessment (CIWA) score less than 8 (indicating no need for medical detox);
  • Must have expressed a desire during their initial screen to reduce the number of drinks they regularly consume

排除标准

  • Currently taking any medications for the treatment of psychiatric disorders, including substance use disorders, mood disorders, and psychosis;
  • Pregnant, as indicated by a pregnancy test which will be administered at baseline;
  • Positive for, sedatives, opiates, cocaine, or amphetamine on drug screen at baseline;
  • Meets criteria for psychotic disorder, bipolar disorder, or a major depressive episode

结局指标

主要结局

Heavy Drinking Days at Baseline

时间窗: Baseline

Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

Heavy Drinking Days at Week 4

时间窗: Week 4

Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

Heavy Drinking Days at Week 8

时间窗: Week 8

Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

Heavy Drinking Days at Week 20

时间窗: Week 20

Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

Heavy Drinking Days at Week 32

时间窗: Week 32

Timeline Follow-back (TLFB) measure of heavy drinking days in the last month (4+ for women, 5+ for men)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验